Combining Immunophenotyping and Artificial Intelligence for Early Cancer Detection

Presentation

Combining the Immunophenotyping of MDSCs and Lymphocytes with Artificial Intelligence (AI) to Predict Early Stage Breast Cancer

Poster

Using artificial intelligence to distinguish subjects with prostate cancer (PCa) from benign prostatic hyperplasia (BPH) through immunophenotyping of MDSCs and lymphocyte cell populations

Presentation Poster

Sign up for email Updates

Be The First to Receive Breaking News

Sign Up Now
Logo Itus

Latest News & Events

Anixa Biosciences Announces Notice of Allowance for Additional Cancer Detection Technology Patent

Read More...

Anixa Biosciences to Present Cchek™ Technology and Data at the Molecular Medicine Tri-Conference

Read More...

Anixa Biosciences to Present Latest Prostate Cancer Data at the 2019 American Association for Cancer Research (AACR) Annual Meeting

Read More...

Cancer of the Lung, Breast, Colon, Prostate, and Stomach are the five most prevalent cancers worldwide.